Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study
2018 ◽
Vol 45
(5)
◽
pp. 529-539
◽
2016 ◽
Vol 44
(4)
◽
pp. 355-362
◽
2021 ◽
Vol 77
(18)
◽
pp. 441
2016 ◽
Vol 362
◽
pp. 266-271
◽
2014 ◽
Vol 71
(6)
◽
pp. 1176-1182
◽
Keyword(s):
2014 ◽
Vol 6
(2)
◽
pp. 210-218
◽
Keyword(s):
2010 ◽
Vol 125
(3)
◽
pp. e65-e70
◽
Keyword(s):